Johnson & Johnson agrees Synthes takeover

Synthes headquarters
Image caption Synthes has agreed to be taken over by J&J

US healthcare giant Johnson & Johnson (J&J) has agreed to buy Swiss medical devices company Synthes in a deal worth 19bn Swiss francs ($21.3bn; £13bn).

Synthes, which does most of its business in the US, makes screws, plates, nails and other implants used to fix broken bones.

J&J wants to add Synthes to its current DePuy orthopaedics business.

J&J chief executive Bill Weldon said that orthopaedics was "a large and growing $37bn global market".

He added it represented "an important growth driver for Johnson & Johnson".

"DePuy and Synthes together will create the most innovative and comprehensive orthopaedics business in the world," he said.

Related Internet links

The BBC is not responsible for the content of external Internet sites